Concord Biotech’s Rollercoaster Week: What Investors Need to Know
Concord Biotech's stock fell sharply by 27.71% in the past week, closing at Rs 1,693.20 on the Bombay Stock Exchange. The biotech sector is highly volatile, with rumors of regulatory…
Unlocking Potential: Biotech Stocks That Could Redefine Long-Term Gains
Vertex Pharmaceuticals and Moderna represent long-term investment opportunities in the biotech sector. Vertex Pharmaceuticals recently achieved FDA approval for Journavx, a non-opioid pain medication, amid the opioid crisis. Vertex continues…
Unlocking IPO Secrets: Your Guide to Future Investment Goldmines
IPOs offer lucrative investment opportunities in the public market. Expert guidance, like that from Donovan Jones at IPO Edge, can reveal valuable insights. Accessing IPO filings and calendars is crucial…